Literature DB >> 6317220

Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice.

P Lesca.   

Abstract

The inhibitory effects of three phenolic compounds (ferulic, chlorogenic and ellagic acids) on benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-induced neoplasia have been investigated in mice. Ellagic acid was the most potent antagonist of tumorigenesis since this compound is active, by i.p. administration or added in the diet, on benzo[a]pyrene-induced pulmonary adenoma formation in A/J mice and, after topical application, on 7,12-dimethylbenz[a]anthracene-induced skin tumorigenesis in NMRI Swiss mice. If ellagic acid has little or no effect on the number of tumor bearing animals, the incidence of pulmonary tumors per animal is decreased by greater than 50%. Ferulic acid and chlorogenic acid (5 X 100 mg/kg, by i.p. route) were also active, but less than ellagic acid, against the lung carcinogenesis by benzo[a]-pyrene (100 mg/kg, i.p.) but were totally ineffective against the formation of skin tumors by 7,12-dimethylbenz[a]anthracene. These results remarkably paralleled the in vitro antimutagenic effects of these compounds shown by Wood et al. on benzo[a]pyrene. It must be noted that ellagic acid only exerted, by i.p. route, a severe toxicity after four injections of 100 mg/kg, in oil suspension, whereas the oral administration in the diet (a daily dose of 100 mg/kg during 15 days) did not cause any toxicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317220     DOI: 10.1093/carcin/4.12.1651

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis.

Authors:  Prabukumar Anitha; Ramamurthi Vidya Priyadarsini; Krishnamurthy Kavitha; Paranthaman Thiyagarajan; Siddavaram Nagini
Journal:  Eur J Nutr       Date:  2011-12-11       Impact factor: 5.614

2.  Ellagic acid toxicity and interaction with benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells.

Authors:  R W Teel; M S Babcock; R Dixit; G D Stoner
Journal:  Cell Biol Toxicol       Date:  1986-03       Impact factor: 6.691

3.  Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems.

Authors:  D D Kitts; A N Wijewickreme
Journal:  Plant Foods Hum Nutr       Date:  1994-04       Impact factor: 3.921

4.  Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid.

Authors:  R Dixit; B Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 5.  Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals.

Authors:  C Nepka; E Asprodini; D Kouretas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

6.  Gene expression signature of DMBA-induced hamster buccal pouch carcinomas: modulation by chlorophyllin and ellagic acid.

Authors:  Ramamurthi Vidya Priyadarsini; Neeraj Kumar; Imran Khan; Paranthaman Thiyagarajan; Paturu Kondaiah; Siddavaram Nagini
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 7.  Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke.

Authors:  S S Hecht
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  Red wine polyphenols for cancer prevention.

Authors:  Shan He; Cuirong Sun; Yuanjiang Pan
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

9.  Ferulic Acid: therapeutic potential through its antioxidant property.

Authors:  Marimuthu Srinivasan; Adluri R Sudheer; Venugopal P Menon
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114

10.  A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat.

Authors:  Gurbet Celik; Aslı Semiz; Serdar Karakurt; Sevki Arslan; Orhan Adali; Alaattin Sen
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.